Ausgabe 3/2010
Inhalt (33 Artikel)
Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer
Anne M. Friel, Claire Corcoran, John Crown, Lorraine O’Driscoll
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Melinda Protani, Michael Coory, Jennifer H. Martin
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis
Alina Vrieling, Katharina Buck, Rudolf Kaaks, Jenny Chang-Claude
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer
Ilenia Migliaccio, Meng-Fen Wu, Carolina Gutierrez, Luca Malorni, Syed K. Mohsin, D. Craig Allred, Susan G. Hilsenbeck, C. Kent Osborne, Heidi Weiss, Adrian V. Lee
Subtypes of familial breast tumours revealed by expression and copy number profiling
Nic Waddell, Jeremy Arnold, Sibylle Cocciardi, Leonard da Silva, Anna Marsh, Joan Riley, Cameron N. Johnstone, Mohammed Orloff, Guillaume Assie, Charis Eng, Lynne Reid, Patricia Keith, Max Yan, Stephen Fox, Peter Devilee, Andrew K. Godwin, Frans B.L. Hogervorst, Fergus Couch, Sean Grimmond, James M. Flanagan, Kumkum Khanna, Peter T. Simpson, Sunil R. Lakhani, Georgia Chenevix-Trench
Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells
Yuhua Zhang, Huaiping Wang, Lijing Wei, Guang Li, Jin Yu, Yan Gao, Peng Gao, Xiaofang Zhang, Fulan Wei, Deling Yin, Gengyin Zhou
A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
Yiing Lin, Shin Lin, Mark Watson, Kathryn M. Trinkaus, Sacha Kuo, Michael J. Naughton, Katherine Weilbaecher, Timothy P. Fleming, Rebecca L. Aft
Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases
Ashley Cimino, Marc Halushka, Peter Illei, Xinyan Wu, Saraswati Sukumar, Pedram Argani
Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta?
Rocío Soldati, Victoria Wargon, Juan Pablo Cerliani, Sebastián Giulianelli, Silvia Inés Vanzulli, María Alicia Gorostiaga, Julieta Bolado, Pablo do Campo, Alfredo Molinolo, Günter Vollmer, Claudia Lanari
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Györffy, Andras Lanczky, Aron C. Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi
Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis
Takayuki Kobayashi, Hitoshi Tsuda, Tomoyuki Moriya, Tamio Yamasaki, Ryoko Kikuchi, Shigeto Ueda, Jiro Omata, Junji Yamamoto, Osamu Matsubara
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate
Christine Y. Shiang, Yuan Qi, Bailiang Wang, Vladimir Lazar, Jing Wang, W. Fraser Symmans, Gabriel N. Hortobagyi, Fabrice Andre, Lajos Pusztai
Gene amplification in ductal carcinoma in situ of the breast
L. Burkhardt, T. J. Grob, I. Hermann, E. Burandt, M. Choschzick, F. Jänicke, V. Müller, C. Bokemeyer, R. Simon, G. Sauter, W. Wilczak, A. Lebeau
Prognostic factors for skeletal complications from metastatic bone disease in breast cancer
Janet E. Brown, Richard J. Cook, Allan Lipton, Luis Costa, Robert E. Coleman
Predicting skeletal complications in metastatic breast cancer raises challenges
Catherine Van Poznak
Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine)
Helene Svensson, Zakaria Einbeigi, Hemming Johansson, Thomas Hatschek, Yvonne Brandberg
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
Teresa Mele, Daniele Generali, Stephen Fox, Maria Pia Brizzi, Alessandra Bersiga, Manuela Milani, Giovanni Allevi, Simone Bonardi, Sergio Aguggini, Marco Volante, Luigi Dogliotti, Alberto Bottini, Adrian Harris, Alfredo Berruti
Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?
David A. Cameron, Sharon Douglas, Janet E. Brown, Richard A. Anderson
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West, Andrew J. Saykin
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
Lesley-Ann Martin, Giles L. S. Davies, Marion T. Weigel, Nadine Betambeau, Margaret J. Hills, Janine Salter, Geraldine Walsh, Roger A’Hern, Mitch Dowsett
Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy
Phuong K. Morrow, Stephen Divers, Louise Provencher, Shiuh-Wen Luoh, Teresa M. Petrella, Marius Giurescu, Thomas Schmelter, Yao Wang, Gabriel N. Hortobagyi, Linda T. Vahdat
Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density
Cornelia W. Taverne, Martijn Verheus, James D. McKay, Rudolf Kaaks, Federico Canzian, Diederick E. Grobbee, Petra H. M. Peeters, Carla H. van Gils
TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls
Dongying Gu, Luhong Zhuang, Huaying Huang, Ping Cao, Danling Wang, Jinhai Tang, Jinfei Chen
TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects
Yongsheng Huang, Binghui Li, Ji Qian, Jingtian Xie, Long Yu
Adipocytokine resistin and breast cancer risk
Chien-An Sun, Mei-Hsuan Wu, Chi-Hong Chu, Yu-Ching Chou, Giu-Cheng Hsu, Tsan Yang, Wan-Yun Chou, Cheng-Ping Yu, Jyh-Cherng Yu
NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Jia-Lei Wang, Shuang-Shuang He, Xi-Chun Hu
Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women
Suleeporn Sangrajrang, Yasunori Sato, Hiromi Sakamoto, Sumiko Ohnami, Thiravud Khuhaprema, Teruhiko Yoshida
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision
Isacco Montroni, Donatella Santini, Giorgia Zucchini, Monica Fiacchi, Simone Zanotti, Giampaolo Ugolini, Alessio Manaresi, Mario Taffurelli
Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation
A. Lasa, T. Ramón y Cajal, G. Llort, J. Suela, J. C. Cigudosa, M. Cornet, C. Alonso, A. Barnadas, M. Baiget
Mouse mammary tumor-like virus and human breast cancer
Wendy K. Glenn, Brian Salmons, James S. Lawson, Noel J. Whitaker
The role of RACK1 as an independent prognostic indicator in human breast cancer
Sara Al-Reefy, Kefah Mokbel